Public Company

AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc. is an American biotechnology company developing medical therapeutics related to human longevity.


AgeX Therapeutics is a regenerative biotechnology company addressing some of the largest unsolved problems by focusing on developing and commercializing novel therapeutics that directly target human aging. The company's revolutionary proprietary technology platform, including iTR™ (induced Tissue Regeneration) and PureStem®, has applications in a range of degenerative diseases with high unmet medical need and regenerative ability to reverse age-related changes in the human body.


Founded 2017
Type Public
Longevity related Yes
Location Alameda, California, USA

Latest News


AGE $0.39 -0.13% $0.00